# US 2023/0266348 A1 · On-site Rapid Quantification of Tetrahydrocannabinol

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0266348 A1
- Document ID: US20230266348A1
- Status: Published application
- Kind: A1
- Application number: 18/017,546
- Filed: 2021-07-26
- Published: 2023-08-24
- Earliest claimed: 2020-07-24
- Assignees: The General Hospital Corporation; Industry-Academic Cooperation Foundation, Yonsei University
- Applicants: The General Hospital Corporation; Industry-Academic Cooperation Foundation, Yonsei University
- Inventors: Hakho Lee; Ralph Weissleder; Hojeong Yu; Jinwoo Cheon
- Web page: https://patentgrep.com/patent/US20230266348A1

## CPC

- B01L 3/50273: {characterised by the means or forces applied to move the fluids}
- G01N 33/948: {Sedatives, e.g. cannabinoids, barbiturates (opiates G01N33/9486)}
- G01N 33/487: of liquid biological material
- G01N 33/54366: {Apparatus specially adapted for solid-phase testing}
- A61B 10/0051: {for taking saliva or sputum samples (devices for receiving spittle A61J9/00)}
- A61B 2010/0009: {Testing for drug or alcohol abuse}
- B01L 2200/0605: Metering of fluids
- B01L 2300/042: Caps; Plugs
- B01L 2300/046: Function or devices integrated in the closure
- B01L 2300/0663: Whole sensors
- B01L 2300/0681: Filter
- B01L 2300/0867: Multiple inlets and one sample wells, e.g. mixing, dilution
- B01L 2300/0896: Nanoscaled
- B01L 2400/0478: pistons
- B01L 2400/0644: rotary valves
- B01L: CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

Aspects of the present disclosure provide devices and methods for rapid, quantitative, on-site detection of controlled substances. Devices include a sample processing module and a sensor cartridge, and optionally a detection cradle.

## Claims

### Claim 1

A device for detecting a controlled substance, the device comprising:
(a) a sample processing module comprising:
a metering reservoir reversibly connected to a sample chamber, an air chamber, and a loading chamber via a first fluidic channel, a second fluidic channel, and a third fluidic channel, respectively,
wherein the metering reservoir is reversibly connected to a waste chamber via a syphon that is configured to actuate upon a predetermined volume of liquid being received in the metering reservoir,
wherein the loading chamber comprises a detection probe that binds a controlled substance, and wherein the loading chamber is connected to a fourth fluidic channel comprising one or more openings;
(b) a sensor cartridge comprising:
a control membrane aligned to the control sample outlet and comprising a loading control probe that binds to the detection probe, and
a test membrane aligned to the test sample outlet and comprising a capture probe comprising the controlled substance; and
(c) a first cap having a protrusion that forms a piston relative to the sample chamber when the first cap is joined to the sample chamber, and a second cap having a protrusion that forms a piston relative to the air chamber when the second cap is joined to the air chamber.

### Claim 2 (depends on 1)

The device of claim 1, wherein the metering reservoir is positionable in a first position where the metering reservoir is aligned with the first fluidic channel to allow fluid to flow from the sample chamber to the metering reservoir.

### Claim 3 (depends on 1)

The device of claim 1, wherein the metering reservoir is positionable in a second position where the metering reservoir is aligned with the second fluidic channel to allow air to flow from the air chamber to the metering reservoir, and where the metering reservoir is aligned with the third fluidic channel to allow fluid to flow from the metering reservoir to the loading chamber.

### Claim 4 (depends on 1)

The device of claim 1, wherein the reservoir has a sample volume of 5 to 50 μL.

### Claim 5 (depends on 4)

The device of claim 4, wherein the reservoir has a sample volume of 15 to 25 μL.

### Claim 6 (depends on 1)

The device of claim 1, wherein the first fluidic channel comprises a filter between the sample chamber and the metering reservoir.

### Claim 7 (depends on 1)

The device of claim 1, wherein the fourth fluidic channel comprising a microfluidic mixer.

### Claim 8 (depends on 1)

The device of claim 1, wherein the detection probe is conjugated to a detectable label.

### Claim 9 (depends on 1)

The device of claim 1, wherein the control membrane and the test membrane are disk shaped.

### Claim 10 (depends on 1)

The device of claim 1, wherein the control membrane and the test membrane are laminated.

### Claim 11 (depends on 1)

The device of claim 1, wherein the loading control probe and the capture probe are immobilized at the center of the control membrane and test membrane, respectively.

### Claim 12 (depends on 1)

The device of claim 1, wherein the sensor cartridge is detachable from the sample processing module.

### Claim 13 (depends on 1)

The device of claim 1, wherein the sensor cartridge comprises a housing.

### Claim 14 (depends on 1)

The device of claim 1, wherein the sample processing module comprises circumferential screw threads, and the first cap and the second cap comprise circumferential receiving threads.

### Claim 15 (depends on 1)

The device of claim 1, further comprising a detection cradle comprising a light source and a lens.

### Claim 16 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15)

A method of detecting a controlled substance in a saliva sample from a subject, the method comprising:
(a) collecting a saliva sample from a subject using an oral swab,
(b) loading the oral swab into the sample processing module of the device of any one of claims 1 to 15,
(c) engaging the first cap with the sample chamber and the second cap with the air chamber, and
(d) determining presence or absence of the controlled substance in the saliva sample based on presence or absence of a signal from the sensor cartridge.

### Claim 17 (depends on 16)

The method of claim 16, wherein the controlled substance is a cannabinoid, an opioid, a stimulant, or a central nervous system (CNS) depressant.

### Claim 18 (depends on 17)

The method of claim 17, wherein the cannabinoid is tetrahydrocannabinol (THC) or tetrahydrocannabivarin (THCV).

### Claim 19 (depends on 17)

The method of claim 17, wherein the opioid is selected from the group consisting of codeine, fentanyl, heroin, hydrocodone, hydromorphone, morphine, and oxycodone.

### Claim 20 (depends on 17)

The method of claim 17, wherein the stimulant is an amphetamine or cocaine.

### Claim 21 (depends on 20)

The method of claim 20, wherein the amphetamine is selected from the group consisting of 3,4-methylenedioxy-methamphetamine (MDMA), dextroamphetamine, methamphetamine, and methylphenidate.

### Claim 22 (depends on 17)

The method of claim 17, wherein the CNS depressant is a barbiturate or a benzodiazepine.

### Claim 23 (depends on 1)

The method of claim 1, wherein the oral swab is rolled in the mouth of the subject.

### Claim 24 (depends on 1)

The method of claim 1, wherein steps (a)-(f) are performed in a total of 1 to 10 minutes.

### Claim 25 (depends on 1)

The method of claim 1, further comprising loading the sensor cartridge into the detection cradle, and determining amount of the controlled substance in the saliva sample based on amount of signal detected from the sensor by a detection device positioned in the detection cradle.

### Claim 26 (depends on 25)

The method of claim 25, wherein the detection device is a mobile electronic device.

### Claim 27 (depends on 26)

The method of claim 26, wherein the mobile electronic device is a mobile phone or a portable computer.
